Black holes in multiple sclerosis: definition, evolution, and clinical correlations
- 10 December 2009
- journal article
- review article
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 122 (1), 1-8
- https://doi.org/10.1111/j.1600-0404.2009.01221.x
Abstract
Magnetic resonance imaging (MRI) is a sensitive paraclinical test for diagnosis and assessment of disease progression in multiple sclerosis (MS) and is often used to evaluate therapeutic efficacy. The formation of new T2-hyperintense MRI lesions is commonly used to measure disease activity, but lacks specificity because edema, inflammation, gliosis, and axonal loss all contribute to T2 lesion formation. As the role of neurodegeneration in the pathophysiology of MS has become more prominent, the formation and evolution of chronic or persistent Tl-hypointense lesions (black holes) have been used as markers of axonal loss and neuronal destruction to measure disease activity. Despite the use of various detection methods, including advanced imaging techniques such as magnetization transfer imaging and magnetic resonance spectroscopy, correlation of persistent black holes with clinical outcomes in patients with MS remains uncertain. Furthermore, although axonal loss and neuronal tissue destruction are known to contribute to irreversible disability in patients with MS, there are limited data on the effect of therapy on longitudinal change in Tl-hypointense lesion volume. Measurement of black holes in clinical studies may elucidate the underlying pathophysiology of MS and may be an additional method of evaluating therapeutic efficacy.Keywords
This publication has 59 references indexed in Scilit:
- The effect of IFNβ-1b on the evolution of enhancing lesions in secondary progressive MSNeurology, 2001
- Glatiramer acetate reduces the proportion of new MS lesions evolving into “black holes”Neurology, 2001
- Enhancement frequency decreases with increasing age in relapsing-remitting multiple sclerosisNeurology, 2001
- The precision of T1 hypointense lesion volume quantification in multiple sclerosis treatment trials: a multicenter studyMultiple Sclerosis Journal, 2000
- Linomide in relapsing and secondary progressive MSNeurology, 2000
- Relapsing-Remitting Multiple Sclerosis: Longitudinal Analysis of MR Images—Lack of Correlation between Changes in T2 Lesion Volume and Clinical FindingsRadiology, 1999
- Quantitative MRI in patients with secondary progressive MS treated with monoclonal antibody Campath 1HNeurology, 1999
- T1 hypointense lesion load in secondary progressive multiple sclerosis: a comparison of pre versus post contrast loads and of manual versus semi automated threshold techniques for lesion segmentationMultiple Sclerosis Journal, 1998
- Accumulation of hypointense lesions ("black holes") on T 1 spin-echo MRI correlates with disease progression in multiple sclerosisNeurology, 1996
- Correlating MRI and clinical disease activity in multiple sclerosisNeurology, 1995